TMS for OCD in Orange County: Advanced Options When Medication Is Not Enough

Obsessive-compulsive disorder is a serious psychiatric condition that extends far beyond habits, routines, or preferences for order. Individuals with OCD experience persistent, intrusive thoughts that generate significant anxiety, often followed by repetitive behaviors or mental rituals aimed at reducing distress. Over time, these cycles can consume hours of the day and significantly disrupt personal, professional, and social functioning.   Standard treatment approaches, including serotonin-based medications and exposure-based psychotherapy, remain essential components of OCD care. Many patients achieve meaningful improvement through these methods. However, a considerable number continue to experience disabling symptoms despite appropriate and sustained treatment efforts. For these individuals, the search for additional, evidence-based options becomes critical.   Transcranial Magnetic Stimulation has emerged as a non-invasive neuromodulation therapy offering new possibilities for patients with treatment-resistant OCD. In Orange County, Resiliency Mind + Body Medicine provides access to BrainsWay Deep TMS within a structured psychiatric care model designed to support both symptom reduction and long-term stability.  

Understanding TMS in the Context of OCD

Transcranial Magnetic Stimulation works by applying targeted magnetic pulses to specific brain regions involved in psychiatric illness. In obsessive-compulsive disorder, research has consistently identified dysfunction within neural circuits that regulate threat perception, cognitive flexibility, and behavioral inhibition. These circuits involve communication between cortical and subcortical brain regions, rather than a single isolated area.   At Resiliency Mind + Body Medicine, OCD treatment is delivered using BrainsWay Deep TMS, an FDA-cleared system specifically approved for obsessive-compulsive disorder. The BrainsWay H-Coil technology is designed to stimulate deeper and broader brain networks than traditional surface TMS systems. This expanded reach allows clinicians to influence the neural pathways implicated in obsessive thinking and compulsive behaviors more comprehensively.   BrainsWay Deep TMS received FDA clearance for OCD following controlled clinical trials demonstrating statistically significant symptom improvement compared to sham treatment. These findings have been published in peer-reviewed journals, including The American Journal of Psychiatry and World Psychiatry. Treatment sessions are conducted on an outpatient basis, without sedation or systemic medication exposure, and patients remain fully alert throughout.  

Patient Concerns and When TMS Is Considered

Patients exploring TMS for OCD often report long-standing symptoms that have proven resistant to conventional interventions. Some describe partial benefit from medication that plateaued over time, while others experienced side effects that limited continued use. Even with high-quality psychotherapy, particularly exposure and response prevention, symptoms may remain intrusive or impairing.   Common questions include whether TMS will worsen anxiety, how it differs from medication, and what degree of improvement is realistic. These concerns are addressed carefully during the evaluation process. From a safety perspective, Deep TMS has demonstrated a favorable profile, with the most common side effects being transient scalp discomfort or mild headache, particularly during early sessions.   TMS is generally considered for adults with moderate to severe OCD who have not achieved adequate relief from medication and therapy. It may also be appropriate for individuals seeking a non-systemic option that does not rely on daily pharmacologic management. Determining appropriateness requires careful diagnostic confirmation and review of prior treatment history.   While BrainsWay Deep TMS follows FDA-cleared protocols, effective care relies on individualized clinical planning. At Resiliency Mind + Body Medicine, treatment begins with a comprehensive psychiatric evaluation that examines symptom patterns, functional impact, and previous treatment responses.   During the initial treatment phase, clinicians determine personalized stimulation settings based on motor threshold measurements to ensure accuracy and tolerability. For OCD, sessions often incorporate brief symptom activation prior to stimulation, a method supported by clinical research to enhance engagement of the relevant neural circuits.   Treatments are typically scheduled five days per week over several weeks. Progress is assessed using validated OCD symptom rating scales, along with regular provider check-ins. Adjustments are made as needed to align treatment with patient response and comfort. This ongoing oversight ensures that care remains both evidence-based and responsive to individual needs.  

The Treatment Experience and Expected Outcomes

Each Deep TMS session lasts approximately 20 to 30 minutes. Patients are seated comfortably while the H-Coil helmet is positioned securely on the head. The sensation is usually described as tapping or pressure on the scalp. While initially unfamiliar, most patients report that the experience becomes more tolerable as sessions continue.   There is no recovery period required after treatment. Patients can resume daily activities immediately, including work and driving. This continuity allows individuals to pursue treatment without disrupting established routines or responsibilities.   Clinical studies of BrainsWay Deep TMS for OCD have shown meaningful reductions in symptom severity, particularly in patients with treatment-resistant illness. Improvements may include decreased intensity of intrusive thoughts, reduced compulsive behaviors, and improved ability to disengage from ritualistic patterns. While responses vary, research suggests that benefits can be sustained, especially when TMS is integrated into an ongoing psychiatric care plan that may include therapy and medication management as appropriate.  

Candidacy and Safety Considerations

BrainsWay Deep TMS for OCD is intended for adults with a confirmed diagnosis of obsessive-compulsive disorder who have not responded sufficiently to standard treatments. Candidates typically have a documented history of medication trials and structured psychotherapy.   Certain medical conditions may limit eligibility, including seizure disorders, specific neurological conditions, or implanted metallic or electronic devices near the head. These factors are carefully evaluated to ensure patient safety.   Equally important is a patient’s ability to commit to the treatment schedule. Consistent attendance over the full course of therapy is essential for achieving optimal outcomes. At Resiliency Mind + Body Medicine, candidacy decisions are made collaboratively, with attention to clinical appropriateness, safety, and realistic expectations.  

Taking the Next Step

For individuals living with OCD that remains disruptive despite comprehensive treatment efforts, BrainsWay Deep TMS offers an FDA-cleared, non-invasive option supported by clinical research. When delivered within a structured psychiatric care model, Deep TMS can provide meaningful symptom relief and improved functional capacity.   Resiliency Mind + Body Medicine offers BrainsWay Deep TMS at two Orange County locations and accepts most major insurance plans, making advanced OCD treatment more accessible to patients seeking medically grounded care. A consultation provides the opportunity to review treatment history, confirm candidacy, and determine whether Deep TMS aligns with an individual’s clinical needs and long-term goals.